Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 7796796)

1.

Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures.

Devinsky O, Faught RE, Wilder BJ, Kanner AM, Kamin M, Kramer LD, Rosenberg A.

Epilepsy Res. 1995 Mar;20(3):241-6.

PMID:
7796796
2.

Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.

Bourgeois B, Leppik IE, Sackellares JC, Laxer K, Lesser R, Messenheimer JA, Kramer LD, Kamin M, Rosenberg A.

Neurology. 1993 Apr;43(4):693-6.

PMID:
8469324
3.

Felbamate monotherapy for partial-onset seizures: an active-control trial.

Faught E, Sachdeo RC, Remler MP, Chayasirisobhon S, Iragui-Madoz VJ, Ramsay RE, Sutula TP, Kanner A, Harner RN, Kuzniecky R, et al.

Neurology. 1993 Apr;43(4):688-92.

PMID:
8469323
4.

Felbamate monotherapy: controlled trial in patients with partial onset seizures.

Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S.

Ann Neurol. 1992 Sep;32(3):386-92.

PMID:
1416808
5.

Felbamate for partial seizures: results of a controlled clinical trial.

Leppik IE, Dreifuss FE, Pledger GW, Graves NM, Santilli N, Drury I, Tsay JY, Jacobs MP, Bertram E, Cereghino JJ, et al.

Neurology. 1991 Nov;41(11):1785-9.

PMID:
1944909
7.

Felbamate in the treatment of refractory partial-onset seizures.

Jensen PK.

Epilepsia. 1993;34 Suppl 7:S25-9.

PMID:
8243375
8.

Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.

CNS Drugs. 2010 Dec;24(12):1041-54. doi: 10.2165/11586830-000000000-00000.

PMID:
21090838
9.

Felbamate in refractory partial epilepsy.

Canger R, Vignoli A, Bonardi R, Guidolin L.

Epilepsy Res. 1999 Mar;34(1):43-8.

PMID:
10194111
10.

Efficacy of felbamate in therapy for partial epilepsy in children.

Carmant L, Holmes GL, Sawyer S, Rifai N, Anderson J, Mikati MA.

J Pediatr. 1994 Sep;125(3):481-6.

PMID:
8071763
11.

Felbamate monotherapy: implications for antiepileptic drug development.

Theodore WH, Albert P, Stertz B, Malow B, Ko D, White S, Flamini R, Ketter T.

Epilepsia. 1995 Nov;36(11):1105-10.

PMID:
7588454
12.
13.

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.

Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S.

Epilepsia. 2009 Aug;50(8):1899-909. doi: 10.1111/j.1528-1167.2009.02160.x. Epub 2009 Jun 1.

PMID:
19490053
14.

Felbamate in the treatment of partial-onset seizures.

Bourgeois BF.

Epilepsia. 1994;35 Suppl 5:S58-61. Review.

PMID:
8039474
15.

Felbamate in the treatment of Lennox-Gastaut syndrome.

Jensen PK.

Epilepsia. 1994;35 Suppl 5:S54-7.

PMID:
8039473
16.

Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.

Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C.

Epilepsia. 2005 Jan;46(1):31-41.

PMID:
15660766
17.

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.

Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.

Epilepsia. 2009 Mar;50(3):398-405. doi: 10.1111/j.1528-1167.2008.01729.x. Epub 2008 Jul 24. Erratum in: Epilepsia. 2009 Apr;50(4):971.

PMID:
18657175
18.

Felbamate as an add-on therapy for refractory epilepsy.

Shi LL, Dong J, Ni H, Geng J, Wu T.

Cochrane Database Syst Rev. 2014 Jul 18;7:CD008295. doi: 10.1002/14651858.CD008295.pub3. Review.

PMID:
25036694
19.
20.

Felbamate as an add-on therapy for refractory epilepsy.

Shi LL, Dong J, Ni H, Geng J, Wu T.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008295. doi: 10.1002/14651858.CD008295.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD008295.

PMID:
21249704
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk